Miromatrix was honored to be on the front page of November 2016's Twin Cities Business Magazine.
Dale Kurschner (Editor in Chief) writes "[...] Miromatrix will gain market share, and eventual market dominance, in the areas where it’s focusing its efforts because of its proprietary technology: It is the only company in the world that can run fluids through an organ’s own vascular structure to flush out all of its cells, and then reverse the process with a patient’s cells before transplanting part or all of the organ into his or her body. And the process does it so well, the organ retains everything needed for it to be infused with cells and brought back to life. No one else has perfected this."
Click the link to read the article.